mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.11 |
0.02 |